FluChip-8G® Insight Evaluated for Enhanced Influenza Surveillance in Southeast Asia InDevR collaborating with Armed Forces Research Institute of Medical Sciences to test FluChip-8G Insight™ BOULDER (12/4/18) — InDevR scientists ...
Read More

Letter from Colorado Governor-elect Jared Polis ...
Read More

FluChip-8G Tested in US and China for Rapid Characterization of Influenza Viruses Duke and Duke Kunshan University collaborating with InDevR Inc. to test the new influenza subtyping assay for ...
Read More

InDevR’s VaxArray Platform to Tackle Measles-Rubella Vaccines VaxArray to improve potency testing for MR vaccines with support from Bill & Melinda Gates Foundation BOULDER (11/8/18) — InDevR announced today that ...
Read More

VaxArray Potency Kit for “Pandemic” Vaccines Fills Gap in Pandemic Preparedness InDevR’s game-changing VaxArray potency test for influenza H5, H7, and H9 vaccines published in npj Vaccines BOULDER (10/8/18) ...
Read More

First Influenza-Specific Neuraminidase Test Kit InDevR’s game-changing VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase in influenza vaccines BOULDER COLORADO (6/12/18) — InDevR ...
Read More